Chempartner Pharmatech's P/S lags behind the industry due to...
Chempartner Pharmatech's P/S lags behind the industry due to falling revenue. Investors believe the potential for revenue improvement doesn't justify a higher P/S ratio. If recent revenue trends continue, significant share price movement seems unlikely.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001638597b2a6ec7.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment